» Articles » PMID: 9808687

Seizure Sensitivity and GABAergic Modulation of Ethanol Sensitivity in Selectively Bred FAST and SLOW Mouse Lines

Overview
Specialty Pharmacology
Date 1998 Nov 10
PMID 9808687
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

FAST and SLOW selected mouse lines were bred for differences in locomotor response to low-dose ethanol. FAST mice exhibit an extreme stimulant response and SLOW mice exhibit locomotor depression at the same ethanol dose. We tested the hypothesis that gamma-aminobutyric acid (GABA) systems modulate ethanol's stimulant effects by examining convulsant responses to GABAA receptor ligands, and by assessing the effects of GABAA and GABAB ligands on locomotor activity in the presence and absence of EtOH. FAST mice were more sensitive to the convulsant effects of GABAA drugs, and to one of two non-GABAergic drugs also tested. FAST and SLOW mice differed in locomotor responses to two benzodiazepines, but not to other GABAA receptor ligands. Ethanol's stimulant effects were not selectively altered by bicuculline or picrotoxin. The selected lines differed in sensitivity to the locomotor depressant effects of the GABAB agonist, baclofen. Ethanol-stimulated activity of FAST mice was inhibited by baclofen, and this effect was reversed by administration of the GABAB antagonist, CGP-35348. These GABAB receptor mediated effects were replicated in DBA/2J inbred mice that exhibit extreme sensitivity to ethanol's stimulant effects. In summary, we found moderate to strong evidence that some sites on the GABAA receptor complex were altered as a consequence of selection of FAST and SLOW mice, but found little support for GABAA mediation of EtOH-stimulated activity. In contrast, we found moderate evidence for differential alteration of GABAB receptor function; however, GABAB receptor involvement in ethanol-stimulated activity was strongly supported by results in the selected lines and an inbred strain.

Citing Articles

Reducing effect of the novel positive allosteric modulator of the GABA receptor, COR659, on binge-like alcohol drinking in male mice and rats.

Lorrai I, Shankula C, Marquez Gaytan J, Kawamura T, Maccioni P, Mugnaini C Psychopharmacology (Berl). 2021; 239(1):201-213.

PMID: 34812900 DOI: 10.1007/s00213-021-06022-3.


Recent Advances in the Potential of Positive Allosteric Modulators of the GABAB Receptor to Treat Alcohol Use Disorder.

Augier E Alcohol Alcohol. 2021; 56(2):139-148.

PMID: 33561865 PMC: 7906877. DOI: 10.1093/alcalc/agab003.


GABA Receptors and Alcohol Use Disorders: Preclinical Studies.

Holtyn A, Weerts E Curr Top Behav Neurosci. 2020; 52:157-194.

PMID: 32808090 DOI: 10.1007/7854_2020_178.


Suppressing Effect of Baclofen on Multiple Alcohol-Related Behaviors in Laboratory Animals.

Colombo G, Gessa G Front Psychiatry. 2018; 9:475.

PMID: 30323777 PMC: 6172300. DOI: 10.3389/fpsyt.2018.00475.


Glyoxalase 1 (GLO1) Inhibition or Genetic Overexpression Does Not Alter Ethanol's Locomotor Effects: Implications for GLO1 as a Therapeutic Target in Alcohol Use Disorders.

Barkley-Levenson A, Lagarda F, Palmer A Alcohol Clin Exp Res. 2018; 42(5):869-878.

PMID: 29532486 PMC: 5915917. DOI: 10.1111/acer.13623.